 Nature.com |
Encapsulated β-cell implants enable glycaemic control
Nature.com Glucose-responsive mature β cells derived from human embryonic stem cells (SC-β cells) are a potential therapy for patients with type 1 diabetes mellitus (T1DM). However, the need for lifelong immunosuppressive therapy has hampered the introduction of … |
